Canlyniadau Chwilio - Schettini, Francesco

Dissecting the biological heterogeneity of HER2-positive breast cancer gan Schettini, Francesco, Prat, Aleix

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A perspective on the development and lack of interchangeability of the breast cancer intrinsic subtypes gan Schettini, Francesco, Brasó-Maristany, Fara, Kuderer, Nicole M., Prat, Aleix

Cael y testun llawn Cael y testun llawn Cael y testun llawn

PI3K/mTOR Inhibitors in the Treatment of Luminal Breast Cancer. Why, When and to Whom? gan Schettini, Francesco, Buono, Giuseppe, Trivedi, Meghana V., De Placido, Sabino, Arpino, Grazia, Giuliano, Mario

Cael y testun llawn Cael y testun llawn Cael y testun llawn

BRAF Signaling Inhibition in Glioblastoma: Which Clinical Perspectives? gan Bouchè, Victoria, Aldegheri, Giovanni, Donofrio, Carmine Antonio, Fioravanti, Antonio, Roberts-Thomson, Samuel, Fox, Stephen B., Schettini, Francesco, Generali, Daniele

Cael y testun llawn Cael y testun llawn Cael y testun llawn

CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors gan Schettini, Francesco, De Santo, Irene, Rea, Carmen G., De Placido, Pietro, Formisano, Luigi, Giuliano, Mario, Arpino, Grazia, De Laurentiis, Michelino, Puglisi, Fabio, De Placido, Sabino, Del Mastro, Lucia

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis gan De Angelis, Carmine, Di Maio, Massimo, Crispo, Anna, Giuliano, Mario, Schettini, Francesco, Bonotto, Marta, Gerratana, Lorenzo, Iacono, Donatella, Cinausero, Marika, Riccardi, Ferdinando, Ciancia, Giuseppe, De Laurentiis, Michelino, Puglisi, Fabio, De Placido, Sabino, Arpino, Grazia

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series gan Schettini, Francesco, Santo, Irene De, Rea, Carmen G., Viggiani, Martina, Buono, Giuseppe, Angelis, Carmine De, Cardalesi, Cinzia, Lauria, Rossella, Giuliano, Mario, Forestieri, Valeria, Thomas, Guglielmo, Maione, Pierfrancesco, Limite, Gennaro, Accurso, Antonello, Malorni, Luca, Placido, Sabino De, Arpino, Grazia

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Frequency and spectrum of PIK3CA somatic mutations in breast cancer gan Martínez-Sáez, Olga, Chic, Nuria, Pascual, Tomás, Adamo, Barbara, Vidal, Maria, González-Farré, Blanca, Sanfeliu, Esther, Schettini, Francesco, Conte, Benedetta, Brasó-Maristany, Fara, Rodríguez, Adela, Martínez, Débora, Galván, Patricia, Rodríguez, Ana Belén, Martinez, Antonio, Muñoz, Montserrat, Prat, Aleix

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study gan Schettini, Francesco, Sobhani, Navid, Ianza, Anna, Triulzi, Tiziana, Molteni, Alfredo, Lazzari, Maria Chiara, Strina, Carla, Milani, Manuela, Corona, Silvia Paola, Sirico, Marianna, Bernocchi, Ottavia, Giudici, Fabiola, Cappelletti, Maria Rosaria, Ciruelos, Eva, Jerusalem, Guy, Loi, Sherine, Fox, Stephen B., Generali, Daniele

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational study gan Buono, Giuseppe, Crispo, Anna, Giuliano, Mario, De Angelis, Carmine, Schettini, Francesco, Forestieri, Valeria, Lauria, Rossella, Pensabene, Matilde, De Laurentiis, Michelino, Augustin, Livia Silvia Adriana, Amore, Alfonso, D'Aiuto, Massimiliano, Tortoriello, Raffaele, Accurso, Antonello, Cavalcanti, Ernesta, Botti, Gerardo, Montella, Maurizio, De Placido, Sabino, Arpino, Grazia

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified accordin... gan Carbognin, Luisa, Simbolo, Michele, Caliò, Anna, Vicentini, Caterina, Delfino, Pietro, Sperduti, Isabella, Fassan, Matteo, Schettini, Francesco, Dieci, Maria Vittoria, Griguolo, Gaia, Pilotto, Sara, Fiorio, Elena, Arpino, Grazia, Guarneri, Valentina, De Placido, Sabino, Conte, Pierfranco, Manfrin, Erminia, Brunelli, Matteo, Scambia, Giovanni, Scarpa, Aldo, Tortora, Giampaolo, Bria, Emilio

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Overall Survival of CDK4/6-Inhibitor–Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-Analysis gan Schettini, Francesco, Giudici, Fabiola, Giuliano, Mario, Cristofanilli, Massimo, Arpino, Grazia, Del Mastro, Lucia, Puglisi, Fabio, De Placido, Sabino, Paris, Ida, De Placido, Pietro, Venturini, Sergio, De Laurentis, Michelino, Conte, PierFranco, Juric, Dejan, Llombart-Cussac, Antonio, Pusztai, Lajos, Prat, Aleix, Jerusalem, Guy, Di Leo, Angelo, Generali, Daniele

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis gan Schettini, Francesco, Giuliano, Mario, Giudici, Fabiola, Conte, Benedetta, De Placido, Pietro, Venturini, Sergio, Rognoni, Carla, Di Leo, Angelo, Locci, Mariavittoria, Jerusalem, Guy, Del Mastro, Lucia, Puglisi, Fabio, Conte, PierFranco, De Laurentiis, Michelino, Pusztai, Lajos, Rimawi, Mothaffar F., Schiff, Rachel, Arpino, Grazia, De Placido, Sabino, Prat, Aleix, Generali, Daniele

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Gene expression profiles of breast cancer metastasis according to organ site gan Brasó‐Maristany, Fara, Paré, Laia, Chic, Nuria, Martínez‐Sáez, Olga, Pascual, Tomás, Mallafré‐Larrosa, Meritxell, Schettini, Francesco, González‐Farré, Blanca, Sanfeliu, Esther, Martínez, Débora, Galván, Patricia, Barnadas, Esther, Salinas, Belinda, Tolosa, Pablo, Ciruelos, Eva, Carcelero, Esther, Guillén, Cecilia, Adamo, Barbara, Moreno, Reinaldo, Vidal, Maria, Muñoz, Montserrat, Prat, Aleix

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study gan Buono, Giuseppe, Crispo, Anna, Giuliano, Mario, De Angelis, Carmine, Schettini, Francesco, Forestieri, Valeria, Lauria, Rossella, De Laurentiis, Michelino, De Placido, Pietro, Rea, Carmen Giusy, Pacilio, Carmen, Esposito, Emanuela, Grimaldi, Maria, Nocerino, Flavia, Porciello, Giuseppe, Giudice, Aldo, Amore, Alfonso, Minopoli, Anita, Botti, Gerardo, De Placido, Sabino, Trivedi, Meghana V., Arpino, Grazia

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy gan Chic, Nuria, Schettini, Francesco, Brasó-Maristany, Fara, Sanfeliu, Esther, Adamo, Barbara, Vidal, Maria, Martínez, Débora, Galván, Patricia, González-Farré, Blanca, Cortés, Javier, Gavilá, Joaquín, Saura, Cristina, Oliveira, Mafalda, Pernas, Sònia, Martínez-Sáez, Olga, Soberino, Jesús, Ciruelos, Eva, Carey, Lisa A., Muñoz, Montserrat, Perou, Charles M., Pascual, Tomás, Bellet, Meritxell, Prat, Aleix

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy gan Martínez-Sáez, Olga, Pascual, Tomás, Brasó-Maristany, Fara, Chic, Nuria, González-Farré, Blanca, Sanfeliu, Esther, Rodríguez, Adela, Martínez, Débora, Galván, Patricia, Rodríguez, Anna Belén, Schettini, Francesco, Conte, Benedetta, Vidal, Maria, Adamo, Barbara, Martínez, Antoni, Muñoz, Montserrat, Moreno, Reinaldo, Villagrasa, Patricia, Salvador, Fernando, Ciruelos, Eva M., Faull, Iris, Odegaard, Justin I., Prat, Aleix

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial gan Schettini, Francesco, Corona, Silvia Paola, Giudici, Fabiola, Strina, Carla, Sirico, Marianna, Bernocchi, Ottavia, Milani, Manuela, Ziglioli, Nicoletta, Aguggini, Sergio, Azzini, Carlo, Barbieri, Giuseppina, Cervoni, Valeria, Cappelletti, Maria Rosa, Molteni, Alfredo, Lazzari, Maria Chiara, Ferrero, Giuseppina, Ungari, Marco, Marasco, Elena, Bruson, Alice, Xumerle, Luciano, Zago, Elisa, Cerra, Davide, Loddo, Marco, Williams, Gareth H., Paris, Ida, Scambia, Giovanni, Generali, Daniele

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer gan Schettini, Francesco, Chic, Nuria, Brasó-Maristany, Fara, Paré, Laia, Pascual, Tomás, Conte, Benedetta, Martínez-Sáez, Olga, Adamo, Barbara, Vidal, Maria, Barnadas, Esther, Fernández-Martinez, Aranzazu, González-Farre, Blanca, Sanfeliu, Esther, Cejalvo, Juan Miguel, Perrone, Giuseppe, Sabarese, Giovanna, Zalfa, Francesca, Peg, Vicente, Fasani, Roberta, Villagrasa, Patricia, Gavilá, Joaquín, Barrios, Carlos H., Lluch, Ana, Martín, Miguel, Locci, Mariavittoria, De Placido, Sabino, Prat, Aleix

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer gan Prat, Aleix, Guarneri, Valentina, Pascual, Tomás, Brasó-Maristany, Fara, Sanfeliu, Esther, Paré, Laia, Schettini, Francesco, Martínez, Débora, Jares, Pedro, Griguolo, Gaia, Dieci, Maria Vittoria, Cortés, Javier, Llombart-Cussac, Antonio, Conte, Benedetta, Marín-Aguilera, Mercedes, Chic, Nuria, Puig-Butillé, Joan Anton, Martínez, Antonio, Galván, Patricia, Tsai, Yi-Hsuan, González-Farré, Blanca, Mira, Aurea, Vivancos, Ana, Villagrasa, Patricia, Parker, Joel S., Conte, Pierfranco, Perou, Charles M.

Cael y testun llawn Cael y testun llawn Cael y testun llawn